What are the major opportunities in the cancer profiling market? What are the strategies for the cancer profiling market?

For detailed insights on the major opportunities and strategies in the cancer profiling market, Read More

How does the cancer profiling market relate to the overall economy and other similar markets?

For detailed insights on cancer profiling market's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the cancer profiling market growth? SWOT analysis of the cancer profiling market.

For detailed insights on the key dynamics influencing the cancer profiling market growth and SWOT analysis of the cancer profiling industry, Read More

Cancer Profiling Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Cancer Profiling Market Report 2026

Name: Cancer Profiling Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Technology (Immunoassays, PCR (Polymerized Chain Reaction), NGS (Next-Generation Sequencing), Microarrays, In-Situ Hybridization), By Biomarker Type (Genomic Biomarkers, Protein Biomarkers), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, Other Cancers), By Application (Research Applications, Clinical Applications, Diagnostics, Prognostics, Other Applications) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Cancer Profiling Market Overview

• Cancer Profiling market size has reached to $15 billion in 2025

• Expected to grow to $25.62 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%

• Growth Driver: Rising Cancer Incidence Fuels Growth In Cancer Profiling Market

• Market Trend: Technological Advancements in the Cancer Profiling Market to Enhance Precision Oncology

• North America was the largest region in 2025.

What Is Covered Under Cancer Profiling Market?

Cancer profiling refers to a diagnostic procedure that is conducted to analyze the genetic information of tumor cells in the body. It provides information about certain molecular or genetic changes in a tumor, such as gene mutations or other changes in tumor DNA.

The main technologies involved in cancer profiling are immunoassays, PCR (polymerized chain reaction), NGS (next-generation sequencing), microarrays, and in-situ hybridization. Immunoassays refer to laboratory tests that measure the concentration of a specific protein or other biomolecules in blood or urine samples. The genomic biomarkers and protein biomarkers are used for profiling various cancers including breast cancer, lung cancer, colorectal cancer, prostate cancer, melanoma cancer, and others for research applications, clinical applications, screening, diagnostics, prognostics, and others.

Cancer Profiling Market Global Report 2026 Market Report bar graph

What Is The Cancer Profiling Market Size and Share 2026?

The cancer profiling market size has grown rapidly in recent years. It will grow from $15 billion in 2025 to $16.67 billion in 2026 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to increasing cancer incidence rates, expansion of molecular diagnostics laboratories, early adoption of genomic testing in oncology, growth in research-based cancer profiling, rising availability of diagnostic platforms.

What Is The Cancer Profiling Market Growth Forecast?

The cancer profiling market size is expected to see rapid growth in the next few years. It will grow to $25.62 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to increasing demand for precision medicine approaches, expansion of companion diagnostics, growing use of liquid biopsy technologies, rising investments in oncology diagnostics, increasing integration of profiling in routine clinical workflows. Major trends in the forecast period include increasing adoption of ngs-based cancer profiling, rising use of comprehensive genomic panels, growing integration of ai in data interpretation, expansion of personalized oncology diagnostics, enhanced focus on early molecular detection.

Book your 30 minutes free consultation with our research experts

Global Cancer Profiling Market Segmentation

1) By Technology: Immunoassays, PCR (Polymerized Chain Reaction), NGS (Next-Generation Sequencing), Microarrays, In-Situ Hybridization

2) By Biomarker Type: Genomic Biomarkers, Protein Biomarkers

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, Other Cancers

4) By Application: Research Applications, Clinical Applications, Diagnostics, Prognostics, Other Applications

Subsegments:

1) By Immunoassays: Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting, Luminex xMAP Technology

2) By PCR (Polymerase Chain Reaction): Quantitative PCR (qPCR), Digital PCR (dPCR), Reverse Transcription PCR (RT-PCR)

3) By NGS (Next-Generation Sequencing): Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted Sequencing, RNA Sequencing (RNA-Seq)

4) By Microarrays: DNA Microarrays, RNA Microarrays, SNP Arrays

5) By In-Situ Hybridization: Fluorescence In-Situ Hybridization (FISH), Chromogenic In-Situ Hybridization (CISH)

What Is The Driver Of The Cancer Profiling Market?

The increasing incidence of cancer is expected to propel the growth of the cancer profiling market going forward. Incidence of cancer refers to the number of new cancer cases in a specific population for a given period. The increased incidence of cancer caused due to urbanization, a growing aging population, changing lifestyles, and environmental and genetic factors. Cancer profiling aids in the identification of specific molecular or genetic changes in a tumor, such as gene mutations or other changes in tumor DNA, which is helpful in the cancer treatment cycle. For instance, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in 2023, an estimated 165,000 Australians were newly diagnosed with cancer, which equates to over 450 cases each day, and males represented about 55% of these diagnoses. Therefore, the increasing incidence of cancer is driving the growth of the cancer profiling industry.

Key Players In The Global Cancer Profiling Market

Major companies operating in the cancer profiling market are Illumina Inc., Qiagen NV, NeoGenomics Inc., Sysmex Corporation, HTG Molecular Diagnostics Inc., Caris Life Sciences, NanoString Technologies Inc., Guardant Health Inc., Foundation Medicine Inc., Roche Diagnostics Corporation, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Genscript Biotech Corporation, Tempus Labs Inc., Hologic Inc., Predictive Oncology Inc., Abbott Laboratories, Agilent Technologies Inc., PerkinElmer Inc., Siemens Healthineers, Genomic Health Inc., Natera Inc., ArcherDX Inc., Personal Genome Diagnostics Inc., Enzo Biochem Inc., Cancer Genetics Inc., OncoDNA SA, Ribomed Biotechnologies Inc., Biocartis Group NV, N-of-One Inc., Cynvenio Biosystems Inc., Inivata Ltd., Burning Rock Biotech Limited, PathAI Inc., GENEWIZ Inc., Genoptix Inc., OmniSeq Comprehensive, Resolution Bioscience, OncoCyte Corporation

Global Cancer Profiling Market Trends and Insights

Major companies operating in the cancer profiling market are focusing on technological advancements such as simultaneous whole-exome sequencing (WES) and whole-transcriptome sequencing (WTS) assays to provide more comprehensive, tissue-sparing, and clinically actionable molecular diagnostics for precision oncology. These assays combine DNA (exome) and RNA (transcriptome) analysis in a single workflow, enabling detection of genomic variants (like SNVs, indels, and copy-number alterations) alongside gene expression or fusion events, unlike traditional NGS tests that require separate assays or limited gene panels. For instance, in November 2024, Caris Life Sciences, a US-based precision medicine company, received FDA approval for MI Cancer Seek, an NGS in vitro diagnostic that performs WES and WTS simultaneously. The assay uses total nucleic acid (TNA) from FFPE tumor tissue to detect single-nucleotide variants, insertions or deletions across 228 genes, microsatellite instability (MSI), tumor mutational burden (TMB), and copy-number amplifications in breast cancer. By integrating DNA and RNA profiling in a single test, it preserves tissue, delivers clinically actionable companion diagnostic (CDx) indications across multiple tumor types, and accelerates therapy selection through a unified genomic blueprint.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Cancer Profiling Market?

In January 2023, Agilent Technologies, a US-based biotechnology research company, acquired Avida Biomed Inc. for an undisclosed amount. This acquisition aims to enhance Agilent's capabilities in the field of molecular biology, particularly in developing innovative tools and technologies for synthetic biology applications. Avida Biomed Inc. is a US-based biotechnology research company.

Regional Outlook

North America was the largest region in the cancer profiling market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cancer Profiling Market?

The cancer profiling market consists of revenues earned by entities by providing services such as surgery, chemotherapy, radiotherapy, hormonal therapy, and immunotherapy services. The market value includes the value of related goods sold by the service provider or included within the service offering. Cancer profiling also includes sales of diagnostic tests and spectrometers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cancer Profiling Market Report 2026?

The cancer profiling market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cancer profiling industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Cancer Profiling Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$16.67 billion
Revenue Forecast In 2035	$25.62 billion
Growth Rate	CAGR of 11.1% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Technology, Biomarker Type, Cancer Type, Application
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Illumina Inc., Qiagen NV, NeoGenomics Inc., Sysmex Corporation, HTG Molecular Diagnostics Inc., Caris Life Sciences, NanoString Technologies Inc., Guardant Health Inc., Foundation Medicine Inc., Roche Diagnostics Corporation, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Genscript Biotech Corporation, Tempus Labs Inc., Hologic Inc., Predictive Oncology Inc., Abbott Laboratories, Agilent Technologies Inc., PerkinElmer Inc., Siemens Healthineers, Genomic Health Inc., Natera Inc., ArcherDX Inc., Personal Genome Diagnostics Inc., Enzo Biochem Inc., Cancer Genetics Inc., OncoDNA SA, Ribomed Biotechnologies Inc., Biocartis Group NV, N-of-One Inc., Cynvenio Biosystems Inc., Inivata Ltd., Burning Rock Biotech Limited, PathAI Inc., GENEWIZ Inc., Genoptix Inc., OmniSeq Comprehensive, Resolution Bioscience, OncoCyte Corporation
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Cancer Profiling Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Cancer Profiling Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Cancer Profiling Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Cancer Profiling Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Increasing Adoption Of Ngs-Based Cancer Profiling

4.2.2 Rising Use Of Comprehensive Genomic Panels

4.2.3 Growing Integration Of Ai In Data Interpretation

4.2.4 Expansion Of Personalized Oncology Diagnostics

4.2.5 Enhanced Focus On Early Molecular Detection

5. Cancer Profiling Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Diagnostic Laboratories

5.3 Research Institutions

5.4 Oncology Clinics

5.5 Biotechnology Companies

6. Cancer Profiling Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cancer Profiling Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Cancer Profiling PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Cancer Profiling Market Size, Comparisons And Growth Rate Analysis

7.3. Global Cancer Profiling Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Cancer Profiling Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cancer Profiling Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cancer Profiling Market Segmentation

9.1. Global Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Immunoassays, PCR (Polymerized Chain Reaction), NGS (Next-Generation Sequencing), Microarrays, In-Situ Hybridization

9.2. Global Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Genomic Biomarkers, Protein Biomarkers

9.3. Global Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, Other Cancers

9.4. Global Cancer Profiling Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Research Applications, Clinical Applications, Diagnostics, Prognostics, Other Applications

9.5. Global Cancer Profiling Market, Sub-Segmentation Of Immunoassays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting, Luminex xMAP Technology

9.6. Global Cancer Profiling Market, Sub-Segmentation Of PCR (Polymerase Chain Reaction), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Quantitative PCR (qPCR), Digital PCR (dPCR), Reverse Transcription PCR (RT-PCR)

9.7. Global Cancer Profiling Market, Sub-Segmentation Of NGS (Next-Generation Sequencing), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted Sequencing, RNA Sequencing (RNA-Seq)

9.8. Global Cancer Profiling Market, Sub-Segmentation Of Microarrays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

DNA Microarrays, RNA Microarrays, SNP Arrays

9.9. Global Cancer Profiling Market, Sub-Segmentation Of In-Situ Hybridization, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Fluorescence In-Situ Hybridization (FISH), Chromogenic In-Situ Hybridization (CISH)

10. Cancer Profiling Market Regional And Country Analysis

10.1. Global Cancer Profiling Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Cancer Profiling Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cancer Profiling Market

11.1. Asia-Pacific Cancer Profiling Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Cancer Profiling Market, Segmentation By Technology, Segmentation By Biomarker Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cancer Profiling Market

12.1. China Cancer Profiling Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Cancer Profiling Market, Segmentation By Technology, Segmentation By Biomarker Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cancer Profiling Market

13.1. India Cancer Profiling Market, Segmentation By Technology, Segmentation By Biomarker Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cancer Profiling Market

14.1. Japan Cancer Profiling Market Overview

14.2. Japan Cancer Profiling Market, Segmentation By Technology, Segmentation By Biomarker Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cancer Profiling Market

15.1. Australia Cancer Profiling Market, Segmentation By Technology, Segmentation By Biomarker Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cancer Profiling Market

16.1. Indonesia Cancer Profiling Market, Segmentation By Technology, Segmentation By Biomarker Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cancer Profiling Market

17.1. South Korea Cancer Profiling Market Overview

17.2. South Korea Cancer Profiling Market, Segmentation By Technology, Segmentation By Biomarker Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cancer Profiling Market

18.1. Taiwan Cancer Profiling Market Overview

18.2. Taiwan Cancer Profiling Market, Segmentation By Technology, Segmentation By Biomarker Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cancer Profiling Market

19.1. South East Asia Cancer Profiling Market Overview

19.2. South East Asia Cancer Profiling Market, Segmentation By Technology, Segmentation By Biomarker Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cancer Profiling Market

20.1. Western Europe Cancer Profiling Market Overview

20.2. Western Europe Cancer Profiling Market, Segmentation By Technology, Segmentation By Biomarker Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cancer Profiling Market

21.1. UK Cancer Profiling Market, Segmentation By Technology, Segmentation By Biomarker Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cancer Profiling Market

22.1. Germany Cancer Profiling Market, Segmentation By Technology, Segmentation By Biomarker Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cancer Profiling Market

23.1. France Cancer Profiling Market, Segmentation By Technology, Segmentation By Biomarker Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cancer Profiling Market

24.1. Italy Cancer Profiling Market, Segmentation By Technology, Segmentation By Biomarker Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cancer Profiling Market

25.1. Spain Cancer Profiling Market, Segmentation By Technology, Segmentation By Biomarker Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cancer Profiling Market

26.1. Eastern Europe Cancer Profiling Market Overview

26.2. Eastern Europe Cancer Profiling Market, Segmentation By Technology, Segmentation By Biomarker Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cancer Profiling Market

27.1. Russia Cancer Profiling Market, Segmentation By Technology, Segmentation By Biomarker Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cancer Profiling Market

28.1. North America Cancer Profiling Market Overview

28.2. North America Cancer Profiling Market, Segmentation By Technology, Segmentation By Biomarker Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cancer Profiling Market

29.1. USA Cancer Profiling Market Overview

29.2. USA Cancer Profiling Market, Segmentation By Technology, Segmentation By Biomarker Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cancer Profiling Market

30.1. Canada Cancer Profiling Market Overview

30.2. Canada Cancer Profiling Market, Segmentation By Technology, Segmentation By Biomarker Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cancer Profiling Market

31.1. South America Cancer Profiling Market Overview

31.2. South America Cancer Profiling Market, Segmentation By Technology, Segmentation By Biomarker Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cancer Profiling Market

32.1. Brazil Cancer Profiling Market, Segmentation By Technology, Segmentation By Biomarker Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cancer Profiling Market

33.1. Middle East Cancer Profiling Market Overview

33.2. Middle East Cancer Profiling Market, Segmentation By Technology, Segmentation By Biomarker Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cancer Profiling Market

34.1. Africa Cancer Profiling Market Overview

34.2. Africa Cancer Profiling Market, Segmentation By Technology, Segmentation By Biomarker Type, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cancer Profiling Market Regulatory and Investment Landscape

36. Cancer Profiling Market Competitive Landscape And Company Profiles

36.1. Cancer Profiling Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Cancer Profiling Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Cancer Profiling Market Company Profiles

36.3.1. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Qiagen NV Overview, Products and Services, Strategy and Financial Analysis

36.3.3. NeoGenomics Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Sysmex Corporation Overview, Products and Services, Strategy and Financial Analysis

36.3.5. HTG Molecular Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Cancer Profiling Market Other Major And Innovative Companies

Caris Life Sciences, NanoString Technologies Inc., Guardant Health Inc., Foundation Medicine Inc., Roche Diagnostics Corporation, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Genscript Biotech Corporation, Tempus Labs Inc., Hologic Inc., Predictive Oncology Inc., Abbott Laboratories, Agilent Technologies Inc., PerkinElmer Inc., Siemens Healthineers

38. Global Cancer Profiling Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cancer Profiling Market

40. Cancer Profiling Market High Potential Countries, Segments and Strategies

40.1 Cancer Profiling Market In 2030 - Countries Offering Most New Opportunities

40.2 Cancer Profiling Market In 2030 - Segments Offering Most New Opportunities

40.3 Cancer Profiling Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Cancer Profiling Market, Overview Of Key Products - Product Examples

Table 2: Global Cancer Profiling Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Cancer Profiling Market, Supply Chain Analysis

Table 4: Global Cancer Profiling Market, Major Raw Material Providers

Table 5: Global Cancer Profiling Market, Major Resource Providers

Table 6: Global Cancer Profiling Market, Major Manufacturers (Suppliers)

Table 7: Global Cancer Profiling Market, Major Distributors And Channel Partners

Table 8: Global Cancer Profiling Market, Key Technologies & Future Trends

Table 9: Global Cancer Profiling Market, Major Trends

Table 10: Global Cancer Profiling Market, Major End Users

Table 11: Global Cancer Profiling Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Cancer Profiling Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Cancer Profiling Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Cancer Profiling Market - TAM, US$ Billion, 2025

Table 15: Global Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Cancer Profiling Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Cancer Profiling Market, Sub-Segmentation Of Immunoassays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Cancer Profiling Market, Sub-Segmentation Of PCR (Polymerase Chain Reaction), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Cancer Profiling Market, Sub-Segmentation Of NGS (Next-Generation Sequencing), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Cancer Profiling Market, Sub-Segmentation Of Microarrays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Cancer Profiling Market, Sub-Segmentation Of In-Situ Hybridization, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Cancer Profiling Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Cancer Profiling Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Global Cancer Profiling Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 99: Global Cancer Profiling Market - Company Scoring Matrix

Table 100: Illumina Inc. Financial Performance

Table 101: Qiagen NV Financial Performance

Table 102: NeoGenomics Inc. Financial Performance

Table 103: Sysmex Corporation Financial Performance

Table 104: HTG Molecular Diagnostics Inc. Financial Performance

Table 105: Global Cancer Profiling Market, Competitive Benchmarking (In USD Billions)

Table 106: Global Cancer Profiling Market, Competitive Dashboard

Table 107: Global Cancer Profiling Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 108: Global, Cancer Profiling Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Table 109: Global, Cancer Profiling Market Size Gain ($ Billion), Segmentation By Biomarker Type, 2025 – 2030

Table 110: Global, Cancer Profiling Market Size Gain ($ Billion), Segmentation By Cancer Type, 2025 – 2030

List Of Figures

Figure 1: Global Cancer Profiling Market, Overview Of Key Products - Product Examples

Figure 2: Global Cancer Profiling Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Cancer Profiling Market, Supply Chain Analysis

Figure 4: Global Cancer Profiling Market, Major Raw Material Providers

Figure 5: Global Cancer Profiling Market, Major Resource Providers

Figure 6: Global Cancer Profiling Market, Major Manufacturers (Suppliers)

Figure 7: Global Cancer Profiling Market, Major Distributors And Channel Partners

Figure 8: Global Cancer Profiling Market, Key Technologies & Future Trends

Figure 9: Global Cancer Profiling Market, Major Trends

Figure 10: Global Cancer Profiling Market, Major End Users

Figure 11: Global Cancer Profiling Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Cancer Profiling Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Cancer Profiling Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Cancer Profiling Market - TAM, US$ Billion, 2025

Figure 15: Global Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Cancer Profiling Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Cancer Profiling Market, Sub-Segmentation Of Immunoassays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Cancer Profiling Market, Sub-Segmentation Of PCR (Polymerase Chain Reaction), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Cancer Profiling Market, Sub-Segmentation Of NGS (Next-Generation Sequencing), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Cancer Profiling Market, Sub-Segmentation Of Microarrays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Cancer Profiling Market, Sub-Segmentation Of In-Situ Hybridization, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Cancer Profiling Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Cancer Profiling Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Cancer Profiling Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Cancer Profiling Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Cancer Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Global Cancer Profiling Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 99: Global Cancer Profiling Market - Company Scoring Matrix

Figure 100: Illumina Inc. Financial Performance

Figure 101: Qiagen NV Financial Performance

Figure 102: NeoGenomics Inc. Financial Performance

Figure 103: Sysmex Corporation Financial Performance

Figure 104: HTG Molecular Diagnostics Inc. Financial Performance

Figure 105: Global Cancer Profiling Market, Competitive Benchmarking (In USD Billions)

Figure 106: Global Cancer Profiling Market, Competitive Dashboard

Figure 107: Global Cancer Profiling Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 108: Global, Cancer Profiling Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Figure 109: Global, Cancer Profiling Market Size Gain ($ Billion), Segmentation By Biomarker Type, 2025 – 2030

Figure 110: Global, Cancer Profiling Market Size Gain ($ Billion), Segmentation By Cancer Type, 2025 – 2030

Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

2025 Healthcare Information Technology (IT) Outsourcing Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Explore the latest trends, growth insights, and forecasts in the Nutrition Analysis Software Global Market.

Cancer Tumor Profiling Market Report 2026 - Global Outlook – By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Stomach Cancer, Pancreatic Cancer, Thyroid Cancer, Ot...

Cancer Biomarker Market Report 2026 - Global Outlook – By Biomarker Type (Protein Biomarkers, Genetic Biomarkers, Other Biomarker Types), By Profiling Technologies (Omics Technologies, Immunoassay, Bioinformatics, Cytoge...

Cancer Diagnostics Market Report 2026 - Global Outlook – By Products (Companion Diagnostics, Molecular Diagnostics), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast ...

Oncology Biomarkers Market Report 2026 - Global Outlook – By Biomarker Type (Protein Biomarkers, Genetic Biomarkers, Other Biomarker Types), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer,...

Genomics In Cancer Care Global Market Report 2025 – By Product Type( Instruments, Consumables, Services), By Technology( PCR (?Polymerase Chain Reaction), MicroArrays, Genome Sequencing, Other Technologies), By Applicati...

Artificial Intelligence In Cancer Diagnostics Market Report 2026 - Global Outlook – By Component (Software Solutions, Hardware, Services), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, B...

Multi Cancer Early Detection Market Report 2026 - Global Outlook – By Type (Liquid Biopsy, Gene Panel, Laboratory Developed Tests (LDT), Other Types), By Cancer Type (Solid Tumors, Hematological Malignancies), By End-Use...

Frequently Asked Questions

How big is the Cancer Profiling Market?

The Cancer Profiling market was valued at $15 billion in 2025, increased to $16.67 billion in 2026, and is projected to reach $25.62 billion by 2030.

What is the Cancer Profiling market growth?

The global Cancer Profiling market is expected to grow at a CAGR of 11.3% from 2026 to 2035 to reach $25.62 billion by 2035.

Who are the key players in Cancer Profiling market?

Some Key Players in the Cancer Profiling market Include, Illumina Inc., Qiagen NV, NeoGenomics Inc., Sysmex Corporation, HTG Molecular Diagnostics Inc., Caris Life Sciences, NanoString Technologies Inc., Guardant Health Inc., Foundation Medicine Inc., Roche Diagnostics Corporation, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Genscript Biotech Corporation, Tempus Labs Inc., Hologic Inc., Predictive Oncology Inc., Abbott Laboratories, Agilent Technologies Inc., PerkinElmer Inc., Siemens Healthineers, Genomic Health Inc., Natera Inc., ArcherDX Inc., Personal Genome Diagnostics Inc., Enzo Biochem Inc., Cancer Genetics Inc., OncoDNA SA, Ribomed Biotechnologies Inc., Biocartis Group NV, N-of-One Inc., Cynvenio Biosystems Inc., Inivata Ltd., Burning Rock Biotech Limited, PathAI Inc., GENEWIZ Inc., Genoptix Inc., OmniSeq Comprehensive, Resolution Bioscience, OncoCyte Corporation .

What is the anticipated growth trend for the Cancer Profiling market?

Major trend in this market includes: Technological Advancements in the Cancer Profiling Market to Enhance Precision Oncology . For further insights on this market. request a sample here

Which region has the most growth potential in the Cancer Profiling market?

North America was the largest region in the cancer profiling market in 2025. The regions covered in the cancer profiling market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.